Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia.

The results of the current study demonstrate that obesity is prevalent, and height growth, especially in patients with identified risk factors, appears compromised. Multidisciplinary intervention should begin during induction therapy and continue during the off-therapy period.